David A. Karlin MD,Hazel B. Breitz MD,Paul L. Weiden MD,Robert De Jager
申请号：
US13319647
公开号：
US20120122825A1
申请日:
2010.05.12
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention provides a method of treatment of metastatic hormone-refractory prostate cancer involving substantially as concurrent administration of picoplatin and docetaxel. Prednisone may also be administered. Dosages and dosing regimens are provided.
